As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...
A crucial step in drug development, bioassay development can take from three months to a year to accomplish. Time, personnel, and budget resources along with reagent, drug lot, and cell-line ...
EMERYVILLE, Calif., May 06, 2025--(BUSINESS WIRE)--Slingshot Biosciences, the leader in precision-engineered cell mimic technologies, today announced the launch of TruCytes™ Potency, a new class of ...
A major challenge preventing transformative gene therapies from reaching patients is the lack of fit-for purpose potency assays, which are some of the most important assays in an analytical package ...
Developing bioassay methods requires a new approach for cell and gene therapy drug development. As cell-based methods continue to evolve in support of gene therapies to assess product potency through ...
HOUSTON, Dec. 3, 2025 /PRNewswire/ -- Avance Biosciences today announced the opening of its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and ...
Immunotherapies show promise, but they’re a long way from perfection. Immunotherapies supercharge the immune system by helping it target and kill tumor cells. This class of treatments is approved to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback